Because PBMs control formulary access for the majority of insured Americans, they retain significant power to marginalize transparent-pricing alternatives, even as those alternatives become more prominent
2.2 GIPR agonism serves to reduce GLP-1R mediated GI AEs in the clinic Treatment with GLP-1R agonists can drive nausea, diarrhea, vomiting, and constipation, which often results in discontinuation of treatment (6-10% of patients) or reduction in dose (~15% of patients) (63)
Autoimmune Conditions: Some autoimmune diseases, like ALPS, may influence B12 transport and metabolism, leading to elevated serum levels
In addition to its role as a GH stimulator, ipamorelin mimics ghrelin, selectively binding to the ghrelin/GHS receptor pathway, influencing anabolic processes like appetite regulation, fat metabolism, and overall energy usage
Thats kind of scary, and thats the No